Declared technologies base

TRANSFER OF INNOVATIONAL TECHNOLOGIES

EMBRIOLAYF DRUG FOR PREVENTION AND TREATMENT OF VIOLATIONS OF MINERAL METABOLISM IN PREGNANT EWES


Purpose of the development: The drug is intended for the prevention and treatment of pathologies of mineral metabolism in pregnant ewes.

Recommended application field: Veterinary medicine. Public and private agricultural enterprises, tribal shepherds of Ukraine.

Advantages over analogues: New veterinary drug.

The development stage readiness: Ready for application

Description of the development:
()
Embriolayf drug characterized by a combination of organic compounds of biogenic macro-and micronutrients and antioxidants. Use of the drug ewes effectively normalizes protein, mineral, carbohydrate and water-electrolyte metabolism, state acid-base balance, prevents the development of structural and functional disorders of the body's systems, and eritrotsitopoez stimulates hemoglobin synthesis, enzyme activity levels, promotes the production of healthy young animals. Embriolayf drug normalizes mineral and other types of metabolism in the body of pregnant sheep, increasing their productive functions and reproducible quality.

Information about newness of the development:


ноу-хау--
1 шт.

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua

or fill out the form:
Organization name :
Address :
Settlement account :
Bank :
MFO :
OKPO code :

Scientific organization tutor's data :
Surname :
Name :
Patronymic :
Scientific degree :
Phone :
Fax :
E-mail :
Cooperation proposals (joint patent, joint enterprise, assembly sale and so on :
country: